Can acthar calm RA flares? new study investigates
NCT ID NCT02541955
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether the drug Acthar can reduce inflammation and improve symptoms during a rheumatoid arthritis (RA) flare. Forty adults with RA who were having a flare took part. Researchers used ultrasound and disease activity scores to measure changes after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- OPTIBIO RA Remission Trial NCT07678112
- Bioequivalence Study of SKI-O-703 in Healthy Adu NCT07675226
- Morning vs Evening JAK Inhibitor for RA (NCT07674134)
- COVID-19 Booster Study for Autoimmune Patients (NCT05000216)
- App-Based Yoga & Meditation for RA Anxiety (NCT07666594)
- BloodTrackR Usability Study for Rheumatoid Arthr NCT07660029
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA David Geffen School of Medicine, Division of Rheumatology
Los Angeles, California, 90095, United States